OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for April, 2012

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you. 2012-04-30 12:00 MannKind says it could get $130M and royalties after licensing drug candidates to Tolero and more... 2012-04-30 00:00 9 Undervalued Healthcare Stocks Being Snapped Up By Hedge Funds and more... 2012-04-29 00:00 Watson, Antares launch Gelnique 3% for overactive bladder treatment and more... 2012-04-28 00:00 FDA Throws Pozen A Curveball and more... 2012-04-27 12:00 Novo Nordisk plans 15 percent expansion of U.S. work force in 2012 and more... 2012-04-27 00:00 Spectrum profit soars on higher sales of colon drug 2012-04-26 12:00 Corcept Therapeutics: Korlym Is Available Now and more... 2012-04-26 00:00 Carl Icahn Plays Nice With Amylin; Shares Jump and more... 2012-04-25 12:00 AstraZeneca Amarin-to-Forest Deal Seen on Lost Patents: Real M&A and more... 2012-04-24 12:00 Questcor Earnings Seen Again Rising By Triple Digits and more... 2012-04-24 00:00 Illumina And Human Genome: Reasons For Rejections Of Takeovers and more... 2012-04-23 12:00 Galena Biopharma: How Long Can Big Pharma Wait? and more... 2012-04-23 00:00 Apricus Biosciences; Vitaros Has Great Potential and more... 2012-04-22 00:00 GlaxoSmithKline sells more noncore brands and more... 2012-04-21 12:00 Partner Up or Get Passed Up and more... 2012-04-20 12:00 Merck KGaA to abstain from major deals until 2013 and more... 2012-04-20 00:00 Bristol-Myers' Daclatasvir, Asunaprevir Cured 77%: Study and more... 2012-04-19 12:00 AstraZeneca Will Tumble If New Dutoprol Drug Fails and more... 2012-04-19 00:00 Arena Pharma's Own Data Point to Weight-Loss Drug Rejection and more... 2012-04-18 12:00 MAP Pharmaceutical: Timeline Of The NDA Resubmission and more... 2012-04-17 12:00 New J&J CEO's ties to fraud case show J&J sees no need for a cure and more... 2012-04-17 00:00 Lilly Declares Second-Quarter 2012 Dividend and more... 2012-04-16 12:00 Johnson & Johnson Won't Blow Out Earnings But Still Worth $72.50 and more... 2012-04-16 00:00 How Does Johnson & Johnson Boost Its Returns? and more... 2012-04-15 00:00 Actos Lawsuits Gaining Momentum In Illinois State Court and more... 2012-04-13 12:00 Affymax gets Medicare payment code for Omontys and more... 2012-04-13 00:00 Rep overtime-pay issue will be argued at the Supreme Court next week and more... 2012-04-12 12:00 Roche Sales Slip, But Hints at Willingness to Lift Illumina Offer and more... 2012-04-12 00:00 Arkansas judge fines J&J $1.1B in Risperdal case and more... 2012-04-11 12:00 Handicapping The Obesity Race and more... 2012-04-11 00:00 Teva May Raise Forecast After Provigil Decision, Analyst Says and more... 2012-04-10 12:00 Amgen to buy KAI Pharma and more... 2012-04-10 00:00 SciClone Pharmaceuticals Is Dramatically Increasing Profits and more... 2012-04-09 00:00 Watch Achillion Pharmaceutical For Upcoming Phase IIa Data and more... 2012-04-08 00:00 Paladin looks beyond Canada and more... 2012-04-07 00:00 Novartis Compound Spurs Cartilage in Arthritic Mice and more... 2012-04-06 12:00 Are These 2 Biotechs About to Be Bought? and more... 2012-04-06 00:00 Spectrum Declines After Bladder Cancer Drug Fails in Study and more... 2012-04-05 12:00 Allos to be acquired by Spectrum Pharma for $206M and more... 2012-04-05 00:00 Idenix Drops as Hepatitis C Drug May Face Hurdles and more... 2012-04-04 12:00 Focus On Upcoming FDA Drug Approval And Advisory Dates and more... 2012-04-03 12:00 Roche, Illumina at Stalemate Ahead of Shareholder Meeting and more... 2012-04-03 00:00 J&J AlzheimerâÔö£é?öé??Ôö£é?ö?ñós Drug May Cut Brain Chemical Tied to Tangles and more... 2012-04-02 12:00 Forest buys hypertension drug rights from J&J and more... 2012-04-02 00:00 Are Ariad's Options Dwindling? and more... 2012-04-01 00:00 AstraZeneca wins Seroquel XR formulation patent case in US and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz

Contact Us Past Issues Unsubscribe